DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Lee JL, Kim MK, Park I. et al.
RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial.
Ann Oncol 2015;
26: 2300-2305
DOI: 10.1093/annonc/mdv357.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.